We are live on ! Find out more
DAVA icon

Endava

184 hedge funds and large institutions have $2.58B invested in Endava in 2022 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 58 increasing their positions, 70 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

721% more call options, than puts

Call options by funds: $20.9M | Put options by funds: $2.55M

1.1% more ownership

Funds ownership: 74.97%76.06% (+1.1%)

6% less funds holding

Funds holding: 195184 (-11)

17% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 70

26% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 39

33% less capital invested

Capital invested by funds: $3.83B → $2.58B (-$1.25B)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
184
Holders Change
-11
Holders Change %
-5.64%
% of All Funds
3.09%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
29
Increased
58
Reduced
70
Closed
39
Calls
$20.9M
Puts
$2.55M
Net Calls
+$18.4M
Net Calls Change
+$188K

DAVA Hedge Fund Activity: Q2 2022 in Review

184 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Endava (DAVA) for Q2 2022, worth a combined $2.58B — down 33% from $3.83B a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of DAVA and 29 opened new positions — a net loss of 10 holders — while 70 trimmed existing stakes and 58 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $102M. The largest seller was Ameriprise, cutting an estimated $34.9M.

  • 184 institutional investors held Endava (DAVA) as of Q2 2022, down from 195 in Q1 2022.
  • Funds reported $2.58B of Endava stock for Q2 2022, down 33% quarter-over-quarter.
  • 29 funds opened new Endava positions in Q2 2022 and 39 closed out, a net change of -10 holders.
  • The largest Endava buyer in Q2 2022 was T. Rowe Price Associates, an estimated $102M added.
  • The largest Endava seller in Q2 2022 was Ameriprise, an estimated $34.9M sold.

Based on aggregated 13F filings for Q2 2022.